## Abstract The alkylating agent 4‐nitroquinoline 1‐oxide (4‐NQO) is a powerful carcinogen and induces squamous cell hyperplasia, squamous cell dysplasia, papilloma, and squamous cell carcinoma (a) in rat oral epithelia. Oral cancers induced by a single application of 4‐NQO develop through a multis
p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats
✍ Scribed by Akira Kido; Toshifumi Tsujiuchi; Masahiro Tsutsumi; Makoto Takahama; Eijiro Okajima; Kunihiko Kobitsu; Yoshizumi Miyauchi; Yoshio Mii; Susumu Tamai; Yoichi Konishi
- Book ID
- 117468400
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 639 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Mutations of __p53__ and Ki‐__ras__ exon 1 were investigated in rat hepatic lesions induced by four kinds of hepatocarcinogenic protocols: continuous feeding of 3′‐methyl‐4‐dimethylaminoazobenzene (3′‐Me‐DAB), daily intraperitoneal injection of aflatoxin B, (AFB,), and the Soft and Farb
Point mutations of the Ki-ras andp53 genes in rat lung lesions induced by N-nitrosobis(2-hydroxypropy1)amine (BHP) were investigated by polymerase chain reaction-single-strand conformation polymorphism analysis followed by direct sequencing using paraffin-embedded tissues. Male Wistar rats 6 wk old
Rat stomach cancers induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) have been widely used as a model for human stomach cancers of the differentiated type. However, there has been little information regarding their molecular basis. In this study, we examined the genetic alterations reported in